NCT04048135 · Interventional trial
A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH
Overall registry status Completed
Phase 1 · Phase 2
Conditions NASH
Delaware Valley sites
- 89bio Clinical Study Site · Berlin, NJ · Camden County
First posted
Registry updated
Added to the directory